RT Journal Article
T1 Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
A1 Argüelles-Arias, F
A1 Guerra Veloz, M F
A1 Perea Amarillo, R
A1 Vilches-Arenas, A
A1 Castro Laria, L
A1 Maldonado Pérez, B
A1 Chaaro, D
A1 Benítez Roldán, A
A1 Merino, V
A1 Ramírez, G
A1 Caunedo Álvarez, A
A1 Romero Gómez, M
YR 2017
FD 2017
LK http://hdl.handle.net/10668/11357
UL http://hdl.handle.net/10668/11357
LA en
DS RISalud
RD Apr 20, 2025